Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02649673
Title LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists-Sarasota Sarasota Florida 34232 United States Details
Oklahoma University Health Science Center/Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field